中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

D-双功能蛋白在肝癌组织中的表达及其与AFP和CA19-9的相关性

路欣 孔令玉 刘殿卿 许林骥 邱宁 程华

引用本文:
Citation:

D-双功能蛋白在肝癌组织中的表达及其与AFP和CA19-9的相关性

DOI: 10.3969/j.issn.1001-5256.2018.10.018
基金项目: 

河北省2018年医学科学研究重点课题计划(20181317); 

详细信息
  • 中图分类号: R735.7

Expression of D-bifunctional protein in hepatocellular carcinoma tissue and its correlation with alpha-fetoprotein and carbohydrate antigen 19-9

Research funding: 

 

  • 摘要: 目的探讨D-双功能蛋白(DBP)在肝细胞癌(HCC)组织中的表达情况,以及与肿瘤血清学标志物AFP、CA19-9表达的相关性,进而分析DBP对HCC早期诊断和预后判断的临床价值。方法选择唐山市妇幼保健院和唐山市人民院2015年6月-2017年5月行肝癌切除术并随访的20例患者作为试验组,同期两所医院的20例健康体检者作为对照组,应用化学发光法检测AFP、CA19-9的表达水平,免疫组化法检测肝癌组织和癌旁组织DBP的表达水平,用积分光密度值(IOD)进行测量。计量资料2组间比较采用t检验,检测指标相关性检验采用Pearson相关分析。结果肝癌组织DBP的IOD值(220. 52±101. 30)明显高于癌旁组织(40. 49±19. 32),差异具有统计学意义(t=-7.00,P <0.01)。且DBP与AFP(r2=0. 868,P <0. 01)和CA19-9(r2=0. 814,P <0. 01)的表达水平均呈正相关。结论 HCC患者DBP表达升高,与HCC的发生发展密切相关,为肝癌的诊断提供新的靶点。

     

  • [1]El-SERAG HB.Hepatocellular carcinoma[J].N Engl J Med, 2011, 365 (12) :1118-1127.
    [2]GHOURI Y, MIAN I, ROWE JH.Review of hepatocellular carcinoma:epidemiology, etiology, and carcinogenesis[J].J Carcinog, 2017, 16:1.
    [3]MOELLER G, ADAMSKI J.Multifunctionality of human 17betahydroxysteroid dehydrogenases[J].Mol Cell Endocrinol, 2006, 248:47-55.
    [4]LU X, MA PP, SHI Y, et al.NF-κB increased expression of 17β-hydroxysteroid dehydrogenase 4promotes HepG2 proliferation via inactivating estradiol[J].Mol Cell Endocrinol, 2015, 401:1-11.
    [5]LIU YW, WU XM.Diagnostic and prognostic significance of AFP, CA199 and CEA levels in patients with hepatocellular carcinoma[J].Lab Med, 2017, 32 (5) :406-409. (in Chinese) 刘永炜, 吴向民.血清AFP、CA199和CEA水平在肝癌诊断和预后中的作用[J].检验医学, 2017, 32 (5) :406-409.
    [6]WANG DX, QUAN WJ, SHI XX, et al.Research of the markers and their detection methods for early diagnosis of hepatocellular carcinoma[J].Anti-Tumor Pharm, 2016, 6 (1) :15-20. (in Chinese) 王丹霞, 全文婕, 史晓欣, 等.肝癌早期诊断标志物及其检测方法的研究进展[J].肿瘤药学, 2016, 6 (1) :15-20.
    [7]CZ HE, KH ZHANG, Q LI, et al.Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer[J].BMC Gastroenterol, 2013, 13:87.
    [8]JIA HL, XING XJ, YE QH, et al.Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma[J].Acta Acad Med Sin, 2008, 30 (4) :440-443. (in Chinese) 贾户亮, 刑戌健, 叶青海, 等.甲胎蛋白在原发性肝癌临床诊断中的应用[J].中国医学科学院学报, 2008, 30 (4) :440-443.
    [9]SUN Y, GAO G, CAI J, et al.AnnexinA2 is a discriminative serologi-calcandidate in early hepatocellular carcinoma[J].Carcinogenesis, 2013, 34 (2) :595.
    [10]LI QR, JI SD.Application of multiple tumor marker protein chip in healthy screening of old people and its clinical significance[J].JJilin Univ:Med Edit, 2016, 42 (3) :535-540. (in Chinese) 李清茹, 季顺东.多肿瘤标志物蛋白芯片检测在老年人健康体检中的应用价值及其临床意义[J].吉林大学学报:医学版, 2016, 42 (3) :535-540.
    [11]HAN ZX, GONG J, ZHENG Y.Combined detection of serum carbohydrate antigens and CEA levels in patients with pancreatic cancer[J].Chin J Med Offic, 2016, 44 (10) :1052-1054. (in Chinese) 韩忠学, 巩静, 郑艳.血清糖类抗原与癌抗原对胰腺癌诊断价值[J].临床军医杂志, 2016, 44 (10) :1052-1054.
    [12]DAI WW, LIU ZX, XU BH.Serum CA125, CA199, AFP, CEA in patients with cirrhosis and primary liver cancer[J].J Pract Hepatol, 2017, 20 (1) :81-84. (in Chinese) 代伟伟, 刘正新, 徐宝宏.肝硬化和肝癌患者血清CA125、CA199、AFP和CEA水平变化[J].实用肝脏病杂志, 2017, 20 (1) :81-84.
    [13]MA HM, TU X.Value of joint detection of AFP, CEA, and CA199in diagnosis for primary live cancer[J].Int J Lab Med, 2016, 37 (12) :1663-1664. (in Chinese) 马海梅, 涂秀.AFP、CEA、CA199联合检测在原发性肝癌中的诊断价值[J].国际检验医学杂志, 2016, 37 (12) :1663-1664.
    [14]ZHU QH.Diagnostic value of joint detection of golgin 73, alphafetoprotein, alpha-fetoprotein variants for primary hepatocellular carcinoma[J].China Med Herald, 2016, 13 (5) :130-133. (in Chinese) 诸琴红.高尔基体蛋白73、甲胎蛋白、甲胎蛋白异质体3%联合检测对原发性肝癌的诊断价值[J].中国医药导报, 2016, 13 (5) :130-133.
    [15]ZHANG Y, XU YY, YAO CB, et al.Acetylation targets HSD17B4 for degradation viathe CMA pathway in response to estrone[J].Autophagy, 2017, 13 (3) :1-16.
    [16]YANG W, LU Y, XU Y, et al.Estrogen represses hepatocellular carcinoma (HCC) growth via inhibiting alternative activation of tumor-associated macrophages (TAMs) [J].J Biol Chem, 2012, 287:40140-40149.
    [17]RASIAH KK, GARDINER-G M, PADILLA EJ, et al.DBP overexpression, an independent biomarker of poor patient outcome in prostate cancer[J].Mol Cell Endocrinol, 2009, 301:89-96.
    [18]SHI L, FENG Y, LIN H, et al.Role of estrogen in hepatocellular carcinoma:Is inflammation the key?[J].J Transl Med, 2014, 12:93.
    [19]NAGAYOSHI Y, OHBA T, YAMAMOTO H, et al.Characterization of 17beta-hydroxysteroid dehydrogenase type 4 in human ovarian surface epithelial cells[J].Mol Hum Reprod, 2005, 11:615-621.
    [20]MALEKI J, NOURBAKHSH M, SHABANI M, et al.17beta-estradiol stimulates generation of reactive species oxygen and nitric oxide in ovarian adenocarcinoma cells (OVCAR3) [J].Iran J Cancer Preven, 2015, 8 (3) :e2332.
  • 加载中
计量
  • 文章访问数:  1928
  • HTML全文浏览量:  32
  • PDF下载量:  353
  • 被引次数: 0
出版历程
  • 出版日期:  2018-10-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回